Mon, January 3, 2011
Fri, December 31, 2010
Thu, December 30, 2010
[ Thu, Dec 30th 2010 ] - Market Wire
Mortgage Rates Jump Again
Wed, December 29, 2010
Tue, December 28, 2010
Mon, December 27, 2010
Fri, December 24, 2010
Thu, December 23, 2010
Wed, December 22, 2010
Tue, December 21, 2010
Mon, December 20, 2010
[ Mon, Dec 20th 2010 ] - Market Wire
Mint.com Goes to School
Sun, December 19, 2010
Sat, December 18, 2010
Fri, December 17, 2010
Thu, December 16, 2010
[ Thu, Dec 16th 2010 ] - Market Wire
Mortgage Rates Hit 5%
Wed, December 15, 2010
[ Wed, Dec 15th 2010 ] - Market Wire
CIBER Hosts Investor Meeting
Tue, December 14, 2010
Mon, December 13, 2010
[ Mon, Dec 13th 2010 ] - Market Wire
Deadly Descents
[ Mon, Dec 13th 2010 ] - Market Wire
EA Unveils Mass Effect 3
Fri, December 10, 2010
Thu, December 9, 2010
Wed, December 8, 2010
Tue, December 7, 2010
Mon, December 6, 2010
Sat, December 4, 2010
Fri, December 3, 2010

Affymetrix Announces Court Order Directing Dismissal of Illumina Patent Infringement Lawsuits


//science-technology.news-articles.net/content/2 .. al-of-illumina-patent-infringement-lawsuits.html
Published in Science and Technology on by Market Wire   Print publication without navigation


SANTA CLARA, Calif.--([ BUSINESS WIRE ])--Affymetrix, Inc. (NASDAQ:AFFX) (the aCompanya) today announced that the U.S. District Court for the Western District of Wisconsin (the aCourta) has granted the companya™s motion for summary judgment that Affymetrix does not infringe the patents held by Illumina, Inc. (NASDAQ: ILMN), and has directed that the patent infringement lawsuits brought against the company by Illumina regarding U.S. Patent Nos. 7,510,841 and 7,612,020 be dismissed and the cases closed.

"We are pleased with the Courta™s ruling, which confirms our position that Illuminaa™s lawsuits were without merit"

aWe are pleased with the Courta™s ruling, which confirms our position that Illuminaa™s lawsuits were without merit,a said Rick Runkel, Affymetrixa™s Executive Vice President, General Counsel and Secretary. aAs a biotechnology company that invests significant time, resources and expertise in R&D, we are committed to conducting our business with the utmost integrity and believe that the Courta™s ruling underscores this commitment.a

About Affymetrix

Affymetrix technology is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes. More than 1,900 systems have been shipped around the world and more than 22,000 peer-reviewed papers have been published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Cleveland, Ohio, and Singapore. The company has about 1,000 employees worldwide and maintains sales and distribution operations across Europe and Asia. For more information about Affymetrix, please visit [ http://www.affymetrix.com ].


Publication Contributing Sources